Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × regorafenib × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 29 Carcinoma, Hepatocellular 12 Glioblastoma 5 Colonic Neoplasms 5 Sarcoma, Ewing 3 Rectal Neoplasms 3 Osteosarcoma 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Leukemia, Myeloid, Acute 2 Gastrointestinal Stromal Tumors 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Chondrosarcoma 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Spinocerebellar Degenerations 1 Solid Malignant Tumors 1 Small Cell Lung Carcinoma 1 Recurrence 1 Patient Compliance 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1

Interventions

Cyclophosphamide 28 fludarabine 20 Whole-Body Irradiation 19 fludarabine phosphate 18 asciminib 18 Mycophenolic Acid 17 nilotinib 14 Tacrolimus 14 Imatinib Mesylate 12 Melphalan 11 Dasatinib 9 ponatinib 8 bosutinib 8 Thiotepa 8 Peripheral Blood Stem Cell Transplantation 7 Busulfan 7 Mesna 6 Granulocyte Colony-Stimulating Factor 6 Filgrastim 5 venetoclax 4 olverembatinib 4 blinatumomab 4 Stem Cell Transplantation 4 Sirolimus 4 ruxolitinib 3 Rituximab 3 Hematopoietic Stem Cell Transplantation 3 Cyclosporine 3 Bone Marrow Transplantation 3 Azacitidine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡